跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bantopraz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bantopraz
Approved
STANDARD
Bantopraz
Rhydburg Pharmaceuticals Limited.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a52b799e134585a2
Company
Rhydburg Pharmaceuticals Limited.
Type
Standard
Approval Details
Approval Id
a52b799e134585a2
Drug Approval Philippines Name
Bantopraz
Product Name
Bantopraz
Registration Number
DRP-15879
Brand Name
Bantopraz
Generic Name
Pantoprazole (as sodium)
Dosage Form
Enteric-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Rhydburg Pharmaceuticals Limited.
Trader
BSD Global Pte. Ltd.
Issuance Date
25 September 2024
Expiry Date
25 September 2029
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a52b799e134585a2
Type
Standard
Back to Philippines FDA Approvals